Canada markets closed

Swedish Orphan Biovitrum AB (B6E.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
22.86+0.12 (+0.53%)
At close: 04:13PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
2,493,000
2,409,000
2,638,000
2,679,000
3,245,000
Depreciation & amortization
2,365,000
3,169,000
2,272,000
2,006,000
2,023,000
Stock based compensation
-
-
-
-
114,000
Change in working capital
-240,000
-1,160,000
-806,000
1,114,000
-441,000
Inventory
286,000
286,000
413,000
-318,000
-1,325,000
Other working capital
3,229,000
-473,000
3,099,000
5,100,000
1,074,000
Other non-cash items
859,000
1,089,000
652,000
529,000
390,000
Net cash provided by operating activites
4,888,000
4,470,000
4,576,000
5,470,000
4,926,000
Cash flows from investing activities
Investments in property, plant and equipment
-1,659,000
-4,943,000
-1,477,000
-370,000
-3,852,000
Acquisitions, net
-16,961,000
-16,961,000
0
-
0
Purchases of investments
-
-
-
0
-120,000
Net cash used for investing activites
-1,659,000
-21,904,000
-1,477,000
-367,000
-3,964,000
Net change in cash
-33,000
-422,000
197,000
629,000
-320,000
Cash at beginning of period
212,000
1,361,000
1,045,000
404,000
737,000
Cash at end of period
179,000
904,000
1,361,000
1,045,000
404,000
Free Cash Flow
Operating Cash Flow
4,888,000
4,470,000
4,576,000
5,470,000
4,926,000
Capital Expenditure
-1,659,000
-4,943,000
-1,477,000
-370,000
-3,852,000
Free Cash Flow
3,229,000
-473,000
3,099,000
5,100,000
1,074,000